CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Total revenues	$ 32,448	$ 42,466
Costs and expenses:
Cost of sales	11,177	5,467
Research and development expenses	733	0
Selling, general and administrative expenses	18,524	16,904
Change in fair value of contingent consideration	0	9,167
Amortization of intangible assets	5,631	6,284
Restructuring charges	720	0
Total costs and expenses	36,785	37,822
(Loss) income from operations	(4,337)	4,644
Other (expense) income:
Debt-related expenses	0	(9,918)
Interest expense	(757)	(1,122)
Other gain	716	802
Total other expense	(41)	(10,238)
Net loss before income taxes	(4,378)	(5,594)
Income tax (expense) benefit	(132)	2,110
Net loss and comprehensive loss	$ (4,510)	$ (3,484)
Basic net loss per share (in dollars per share)	$ (0.05)	$ (0.07)
Diluted net loss per share (in dollars per share)	$ (0.05)	$ (0.07)
Shares used in computing basic net loss per share (in shares)	94,980	51,005
Shares used in computing diluted net loss per share (in shares)	94,980	51,005
Product sales, net
Revenues:
Total revenues	$ 31,862	$ 41,769
Royalties and milestones
Revenues:
Total revenues	$ 586	$ 697